Sentences with phrase «vaccine study in»

Statement from Planned Parenthood Federation of America Senior Director of Medical Services Dr. Deborah Nucatola on New HPV Vaccine Study in the Journal Pediatrics

1997 — Led the development of HIV vaccines for global deployment — In 1997, MHRP launched the first non-subtype B vaccine study in Thailand.

2015 — Began a new Ebola vaccine study in Abuja, Nigeria, using a monovalent chimpanzee adenovirus Type 3 (ChAd3) candidate developed at the NIAID and being developed by GlaxoSmithKline (GSK), the study sponsor.

• RV217 (ECHO): HIV - 1 Prevalence, Incidence, Cohort Retention, and Host Genetics and Viral Diversity in High Risk Cohorts in East Africa • Infectious Disease Surveillance (HIV, TB and Malaria) and Cohort Development Among Urban and Rural Communities • Karolinska Institute vaccine study in Tanzania testing a prime - boost HIV vaccine regimen using unadjuvanted DNA vaccines followed by a Modified Vaccinia Ankara (MVA), which was developed by MHRP and NIAID.

G.K.S. is on a Data and Safety Monitoring Board for a GlaxoSmithKline - funded RSV vaccine study in pregnant women.

«Cholera vaccine study in Haiti suggests problems with current booster regimen.»

Vaccine studies in infants < 6 mo with novel vaccine candidates have generally demonstrated poor immunogenicity (90).

Not exact matches

Inovio's vaccine against HPV is currently in Phase II clinical studies, and Kim says «about 50 percent» of the subjects in that trial are defeating the disease.

But while thousands of clinical trials on immunotherapy drugs, of which many are predicted to fail, are springing up, the depth of information on neoantigen vaccines is much shallower: Just two studies on neoantigen vaccines for melanoma, recently profiled in Nature, were completed last year in Boston and Germany.

In 2015, researchers at the University of Washington's Cancer Vaccine Institute published a study on designing vaccines to prevent breast cancer.

There have been some pieces in recent years in Time and the NYT, but overall, I see little about it in the media in contrast with, say autism or vaccines, anyway, where any little study seems to get covered.

In essence, the HPV vaccine will continue to be advised against during pregnancy until more research confirms what this study has found.

There are now two rotavirus vaccines for infants, and studies indicate a dramatic drop in the number of new cases.

Not only would the new method, tested only in mice, be more convenient but also more effective than the flu shot or nasal spray, according to a study at the International Vaccine Institute in Seoul.

Whenever vaccines are questioned, the name of Dr. Andrew Wakefield and the study he co-authored in 1998 are cited and discredited.

In particular, much of our Division's past research has focused on vaccine studies and investigations into the cause of Kawasaki disease.

A recent study found a 116 fold increase in fetal death presumably caused by flu vaccines.

A well conducted study published in the Italian medical journals in June 2007 demonstrated that the daily intake of Colostrum can be 3x more effective than the flu vaccine for providing protection.

The manufacturer of the sole dengue vaccine on the market says a new study shows that it should only be used in people who have had a previous infection from the mosquito - borne virus.

A 2016 Pediatrics study found that, within six years of the first vaccine's introduction in 2006, infections with the four HPV types covered decreased 64 percent among 14 - to 19 - year - old girls.

This high variability of influenza virus in the study region (and other subtropical / tropical climates) will require improved vaccines with broader antigenic coverage, the authors report.

There were 111 infant deaths during the study — 50 in the placebo group and 51 in the vaccine group; and seven maternal deaths — five in the placebo group and two in the vaccine group.

In the new study, the method accurately predicted vaccine efficacy rates for more than 40 years of flu records.

In the new study, researchers at the NIAID used a virus - like particle vaccine cocktail that expressed a handful of different subtypes of a key surface protein of the influenza virus: hemagglutinin H1, H3, H5 and H7.

A new study shows pregnant women who get flu shots regularly have a weaker peak antibody response to the vaccine than women who don't get them regularly, though mothers and their babies in both groups were well - protected at the time of delivery.

Published in The Journal of Rural Health, the study involved research nurses administering the first dose of the HPV vaccine series free of charge to Appalachian Kentucky women aged 18 - 26.

In a preliminary study published in the April Journal of the American Medical Association, the researchers found that the vaccine produced by this method protects against the two strains to which the subjects were exposed and most likely protects against the thirIn a preliminary study published in the April Journal of the American Medical Association, the researchers found that the vaccine produced by this method protects against the two strains to which the subjects were exposed and most likely protects against the thirin the April Journal of the American Medical Association, the researchers found that the vaccine produced by this method protects against the two strains to which the subjects were exposed and most likely protects against the third.

The study, «The efficacy of the BCG vaccine against newly emerging clinical strains of Mycobacterium tuberculosis,» was published in the journal PLOS One in September.

Study authors intend to perform additional research in the future to follow up on their estimate of how well the current vaccines protect against HPV - associated cancers.

Dr Alice Forster, study author and Cancer Research UK scientist at University College London, said: «Although around 87 per cent of girls in the UK do have the vaccine it's concerning to see that some girls from some ethnic minority groups feel they don't need to have it.

Ferris, first author of the new study who led trials of the quadrivalent vaccine in 2002, says the earlier, shorter - term evaluation clearly indicated the vaccine worked.

«Study offers new recommendations for TB vaccine testing in humans.»

The new formula's reduced effectiveness is most likely driving the recent epidemics of pertussis, says the study's lead author, Nicola Klein, co-director of Kaiser Permanente Vaccine Study Center in Oakland, Castudy's lead author, Nicola Klein, co-director of Kaiser Permanente Vaccine Study Center in Oakland, CaStudy Center in Oakland, Calif..

At Kaiser Permanente Northern California, which conducted the study, the first use of the new DTaP was in the vaccine's fifth booster shot in 1991, followed by its use for the fourth booster the next year.

Dr. David Cavanagh, of the University of Edinburgh's School of Biological Sciences, who led the study, said: «There is a desperate need for an effective vaccine, which can be made easily in large quantities, to protect against this devastating disease.

Protection against the disease pertussis, or whooping cough, doesn't appear to be as strong with the currently administered vaccine when compared with the older version administered up until the 1990s, according to a new study in Pediatrics.

The vaccine administered in the study was for viral influenza — a disease against which doctors recommend patients be vaccinated annually.

Studies that compare flu alterations in multiple people won't immediately tell researchers how to design vaccines, she says, but could point to parts of the virus for further investigation.

For thimerosal, the IOM looked at five studies, examining populations in Sweden, Denmark, the United Kingdom, and the United States (studies that vaccine critics contend were flawed).

CCR5 should remain «a very important target for vaccines and drugs,» he says, noting that they have found only one person with the double CCR5 defect in 300 people studied so far.

Yet there is reason for optimism: the NIH has already developed a DNA vaccine against the West Nile virus that appeared promising in early human studies (although ultimately the NIH could not find a commercial partner to take that vaccine forward).

A multi-institutional study, as reported in the journal Infection Control and Hospital Epidemiology, shows that mandatory flu vaccines for healthcare workers improve vaccination rates by as much as 30 percent and reduce absenteeism during critical periods by about six percent.

These study results highlighting this promising strategy are published in npj Vaccines.

Babies inoculated with a commonly used five - in - one vaccine to protect against a range of potentially lethal childhood diseases face up to a six-fold increased risk of fever - associated seizures on the day they are vaccinated, according to a study of nearly 380,000 Danish children.

In the study, a tipping point represented the point at which vaccine coverage declines dramatically due to spreading fear, which could cause large disease outbreaks due to a loss of population immunity.

In adults, studies have suggested that the anthrax vaccine is quite safe; it's made with inactivated protein from the anthrax bacteria, much like vaccines that protect against diptheria and tetanus.

«We have followed a less potent neutralizing lineage in this particular individual before, but now we have found a far more potent antibody and have been able to study its development over six years,» said first author Mattia Bonsignori, M.D., of the Duke Human Vaccine Institute.

The company plans in October to conduct a separate test specifically to study the seasonal flu vaccine's effectiveness among 480 elderly participants (a demographic often encouraged to get seasonal flu shots), and Phase III efficacy trials across a larger set of demographics are scheduled to begin early next year.

A resurgence in whooping cough cases in the U.S. is likely due to incomplete vaccine coverage in the past combined with waning protection from the vaccine, according to a new study published in the March 28 issue of Science Translational Medicine.

«Based on epidemiological studies, the 9vHPV vaccine could prevent approximately 90 percent of cervical cancer, 90 percent of HPV - related vulvar and vaginal cancer, 70 to 85 percent of high - grade cervical disease in females, and approximately 90 percent of HPV - related anal cancer and genital warts in males and females worldwide,» explained Anna R. Giuliano, Ph.D., Director of the Center for Infection Research in Cancer at Moffitt.